Journals / Nöropsikiyatri Arşivi / 2013 / Cilt: 50 - Sayı: 1

Predicrors of Mortality and Morbidity in acute ischemic stroke

Akut iskemik inmede Mortalite ve Morbidite belirteçleri

Pages
40–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, prospective studies investigating the effect of homocysteine, folic acid, vit B12, MCV on the prognosis of stroke are required. (Archi ves of Neuropsychi atry 2013; 50: 40-44)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Stroke, despite improvements in treatment is still a serious cause of mortality and morbidity.
📊
Key Findings & Data:In this study, prognostic indicators such as erythrocyte sedimentation rate (ESR), folate, vitamin B12 (vit B12), mean corpuscular volume (MCV), white blood cell (WBC) count, hematocrit, glucose were investigated to help determining the course of the treatment.
💡
Conclusion & Impact:Therefore, prospective studies investigating the effect of homocysteine, folic acid, vit B12, MCV on the prognosis of stroke are required. (Archi ves of Neuropsychi atry 2013; 50: 40-44)
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Stroke, despite improvements in treatment is still a serious cause of mortality and morbidity. The most important prognostic factors of stroke are known as the neurological condition of the patient in first hours, the size of the lesion that imaging revealed, and the age. In this study, prognostic indicators such as erythrocyte sedimentation rate (ESR), folate, vitamin B12 (vit B12), mean corpuscular volume (MCV), white blood cell (WBC) count, hematocrit, glucose were investigated to help determining the course of the treatment. Method: In this retrospective study 272 ischemic stroke patients admitted to our emergency department and neurology clinic within the first 24 hours were included. Early laboratory findings were recorded. The patients were categorized into two groups as good and poor prognosis, based on their modified rankin scores at the time of hospital discharge. Patients’ ages, laboratory results, length of the hospitalization, and medical histories were compared. Results: Hypertension was found to be the highest ranked stroke risk factor among the patients. Statistically significant difference was detected on age, MCV, folic acid, WBC, and ESR between groups with good and poor prognosis. Logistic regression analysis revealed that advanced age, high MCV and low folate are associated with poor prognosis. Discussion: Advanced age is the most important predictor of poor outcome. High MCV and low folate levels are also contribute to the mortality and morbidity rates. Both parameters are related to hyperhomocysteinemia, which is one of the risk factors of stroke. Therefore, prospective studies investigating the effect of homocysteine, folic acid, vit B12, MCV on the prognosis of stroke are required. (Archi ves of Neuropsychi atry 2013; 50: 40-44)

Özet

ÖZET Amaç: İnme, tedavisindeki gelişmelere rağmen hala ciddi bir mortalite ve morbidite sebebidir. İnmenin erken döneminde hastanın ilk saatlerdeki nörolojik tablosu, görüntülemede saptanan lezyon büyüklüğü ve yaş en önemli prognostik faktörler olarak bilinmektedir. Bu çalışmada iskemik inmenin ilk saatlerinde glikoz, hemoglobin, hematokrit, beyaz küre (BK), ortalama eritrosit hacmi (Mean corpuscular volume: MCV), vitamin B12, folik asit, sedimantasyon gibi acil poliklinik şartlarında bakılabilecek, takip ve tedavi konusunda yönlendirici olabilecek prognostik belirteçlerin varlığını araştırdık. Yöntem: Bu retrospektif çalışmaya 2006-2011 yılları arasında hastanemize ilk 24 saat içinde başvuran 272 iskemik inmeli hasta alındı. Erken dönemdeki laboratuvar bulguları kaydedildi. Hastalar çıkış tarihlerindeki modifiye rankin skorlarına göre iyi ve kötü prognozlu grup olarak ikiye ayrıldı. Hastaların yaşları, laboratuvar sonuçları, hastanede kalış süreleri ve özgeçmişleri karşılaştırıldı. Bulgular: Hastalarımızda hipertansiyon inme risk faktörleri arasında ilk sırada idi. İyi ve kötü prognozlu gruplar arasında yaş, MCV, folik asit, BK ve sedimantasyon değerlerinde anlamlı farklılıklar vardı. Parametrelerin bağımsız değişkenler olarak lojistik regresyon analizi yapıldığında ileri yaş, yüksek MCV, düşük folik asit kötü prognozla anlamlı şekilde ilişkiliydi. Tartışma: İleri yaş inmede kötü pronozun en önemli belirtecidir. Yüksek MCV ve düşük folik asit düzeyleri de mortalite ve morbiditeyi etkilemişlerdir. Her iki parametre inme risk faktörlerinden biri olan hiperhomosisteinemi ile ilişkilidir. Dolayısıyla iskemik inmede erken dönemde homosistein, folik asit, vit B12, MCV düzeylerinin inme prognozuna etkisini araştıran prospektif çalışmalara ihtiyaç vardır. (Nöropsikiyatri Arflivi 2013; 50: 40-44) Anahtar kelimeler: İskemik inme, prognoz, homosistein, folik asit

🔖

Cite This Article

AKSOY, D., İNANIR, A., AYAN, M., ÇEVİK, B., KURT, S. G., KARAER, H. Ü. (2013). Predicrors of Mortality and Morbidity in acute ischemic stroke. Nöropsikiyatri Arşivi, Cilt: 50 - Sayı: 1, 40–44. https://ajindex.com/articles/292491

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. KayTee Khaw. Epidemiology of stroke. Journal of Neurology, Neurosurgery, and Psychiatry 1996; 61:333-338.
  2. Antonio Carolei, Simona Sacco, Federica De Santis, Carmine Marini. Epidemiology of stroke. Clinical and Experimental hypertension 2002; 24:479-483. American Hearth Association ∕ American Stroke Association Stroke Council. Primary Prevention of Ischemic Stroke. Stroke 2006; 37:1583-1633.
  3. Thompson DW, Furlan AJ. Clinical epidemiology of stroke. Neurology Clin 1996; 14: 309-315. Warlow CP. Epidemiology of stroke. Lancet 1998; 352(Suppl 3):1-4.
  4. Apelros P, Nydevik I, Viitanen M. Poor outcome after-everstroke: Predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003; 34:122- 126. Heuschmann PU, Wiedmann S, Wellwood I, Rudd A, Di Carlo A, Bejot Y, Ryglewicz D, Rastenyte D, Wolfe CD; European Registers of Stroke. Three-month stroke outcome: The European Registers of Stroke (EROS) Investigators. Neurology 2011; 76:159-165.
  5. Weimar C, Ziegler A, König IR, Diener HC. Predicting functional outcome and survival after acute ischemic stroke. J Neurol 2002; 249:888-895.
  6. Czlonkowska A, Ryglewicz D, Lechowicz W. Basic analiytical parameters as the predictive factors for 30-day case fatality rate in stroke. Acta Neurol Scand 1997; 95:121-124.
  7. Chamorro A, Vila N, Ascaso C, Chamorro A, Vila N, Ascaso C. Early prediction of stroke severity. Role of erythrocyte sedimentation rate. Stroke 1995; 26:573-576.
  8. Yan J, Liao JK, Wang D. Elevated homocysteine and C-reaktive protein levels independently predict worsening prognosis after stroke in Chines patients. J Huazhong Univ Sci Technolog Med Sci 2010; 30:643-647.
  9. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of long term follow up study. BMJ 1997; 314:1303-1315.
  10. Kostulas N, Markaki I, Cansu H, Masterman T, Kostulas V. Hyperglycaemia in acuteischaemic stroke is associated with an increased 5-year mortality.Age and Ageing 2009; 38:590-594.
  11. Castillo J, Martinez F, Leira R. Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc Dis 1994; 4:66-71. Van Swieten JC,Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for theassessment of handicap in stroke patients. Stroke 1998; 19:604- 607. Young FB, Lees KR, Weir CJ, Glycine Antagonist in Neuroprotection International Trial Steering Committee and Investigators. Strengthening acute stroke tria